XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Balance at beginning of period (in shares) at Dec. 27, 2019   58,140,000        
Balance at beginning of period at Dec. 27, 2019 $ 636,927 $ 581 $ 654,420 $ (18,134) $ (39) $ 99
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (19,018)     (18,994)   (24)
Foreign currency translation adjustments (434)       (434)  
Equity-based compensation 1,362   1,362      
Balance at end of period (in shares) at Mar. 27, 2020   58,140,000        
Balance at end of period at Mar. 27, 2020 618,837 $ 581 655,782 (37,128) (473) 75
Balance at beginning of period (in shares) at Dec. 27, 2019   58,140,000        
Balance at beginning of period at Dec. 27, 2019 636,927 $ 581 654,420 (18,134) (39) 99
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (20,844)          
Foreign currency translation adjustments (32)          
Balance at end of period (in shares) at Sep. 25, 2020   59,217,000        
Balance at end of period at Sep. 25, 2020 620,113 $ 592 658,381 (38,924) (71) 135
Balance at beginning of period (in shares) at Mar. 27, 2020   58,140,000        
Balance at beginning of period at Mar. 27, 2020 618,837 $ 581 655,782 (37,128) (473) 75
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Capital contributions 243   243      
Net (loss) income (3,229)     (3,213)   (16)
Foreign currency translation adjustments 117       117  
Equity-based compensation 1,185   1,185      
Issuance of common stock (in shares)   1,077,000        
Issuance of common stock 0 $ 11 (11)      
Balance at end of period (in shares) at Jun. 26, 2020   59,217,000        
Balance at end of period at Jun. 26, 2020 617,153 $ 592 657,199 (40,341) (356) 59
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Capital contributions 247   157     90
Net (loss) income 1,403     1,417   (14)
Foreign currency translation adjustments 285       285  
Equity-based compensation 1,025   1,025      
Balance at end of period (in shares) at Sep. 25, 2020   59,217,000        
Balance at end of period at Sep. 25, 2020 $ 620,113 $ 592 658,381 (38,924) (71) 135
Balance at beginning of period (in shares) at Dec. 25, 2020 59,217,000 59,217,000        
Balance at beginning of period at Dec. 25, 2020 $ 617,739 $ 592 659,093 (43,018) 756 316
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (6,036)     (6,014)   (22)
Foreign currency translation adjustments (52)       (52)  
Equity-based compensation 1,060   1,060      
Balance at end of period (in shares) at Mar. 26, 2021   59,217,000        
Balance at end of period at Mar. 26, 2021 $ 612,711 $ 592 660,153 (49,032) 704 294
Balance at beginning of period (in shares) at Dec. 25, 2020 59,217,000 59,217,000        
Balance at beginning of period at Dec. 25, 2020 $ 617,739 $ 592 659,093 (43,018) 756 316
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (28,632)          
Foreign currency translation adjustments (508)          
Equity-based compensation $ 16,629          
Balance at end of period (in shares) at Sep. 24, 2021 74,238,000 74,238,000        
Balance at end of period at Sep. 24, 2021 $ 751,483 $ 742 821,827 (71,605) 248 271
Balance at beginning of period (in shares) at Mar. 26, 2021   59,217,000        
Balance at beginning of period at Mar. 26, 2021 612,711 $ 592 660,153 (49,032) 704 294
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Equity Contributions 10,025   10,025      
Net (loss) income (1,056)     (1,044)   (12)
Foreign currency translation adjustments 32       32  
Equity-based compensation 1,178   1,178      
Balance at end of period (in shares) at Jun. 25, 2021   59,217,000        
Balance at end of period at Jun. 25, 2021 622,890 $ 592 671,356 (50,076) 736 282
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (21,540)     (21,529)   (11)
Foreign currency translation adjustments (488)       (488)  
Equity-based compensation 14,391   14,391      
Issuance of common stock (in shares)   15,021,000        
Issuance of common stock 249,154 $ 150 249,004      
Establishment of income tax receivable liability (112,681)   (112,681)      
Other (in shares)   0        
Other $ (243) $ 0 (243)      
Balance at end of period (in shares) at Sep. 24, 2021 74,238,000 74,238,000        
Balance at end of period at Sep. 24, 2021 $ 751,483 $ 742 $ 821,827 $ (71,605) $ 248 $ 271